Trials / Completed
CompletedNCT04654182
Evaluation of the Residual Antimicrobial Efficacy of One Test Material Based on a Modification of ASTM E1115-11 Test Method
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Molnlycke Health Care AB · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the residual antimicrobial effectiveness of one test product when tested using a modification of the methodology of the standardized ASTM E115-11 (2017)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chlorhexidine Gluconate | Product used in accordance with manufacturers Hand Hygiene instructions |
Timeline
- Start date
- 2020-11-30
- Primary completion
- 2020-12-24
- Completion
- 2020-12-24
- First posted
- 2020-12-04
- Last updated
- 2021-02-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04654182. Inclusion in this directory is not an endorsement.